Filtered Search Results
R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
---|---|
Conjugate | Unconjugated |
Molecular Weight (g/mol) | alpha chain: 53.7 kDa beta chain: 26 kDa |
Gene Symbol | HGF |
Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
For Use With (Application) | Bioactivity |
Source | Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile) |
Accession Number | P14210.2 |
Regulatory Status | RUO |
Gene Alias | deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A |
Gene ID (Entrez) | 3082 |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Cross Reactivity | HGF |
Species | Human |
R&D Systems™ Recombinant Mouse HGFR/c-MET Fc Chimera (NS0-expressed)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
---|---|
Conjugate | Unconjugated |
Gene Alias | deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A |
Gene ID (Entrez) | 3082 |
Structural Form | Disulfide-linked heterodimer |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Source | Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile) |
Recombinant | Recombinant |
Name | HGF |
R&D Systems™ N21-MAX Media Supplement (50X)
For long-term culture of neurons under fully defined, serum-free conditions
R&D Systems™ Endothelial Cell Growth Supplement (50X)
Media supplement for low-serum expansion of primary endothelial cells.
R&D Systems™ StemXVivo Human/Mouse Chondrogenic Supplement, 0.5 mL
Media supplement to induce the differentiation of MSCs into chondrocytes
R&D Systems™ StemXVivo Cardiomyocyte Maintenance Media Supplement (50X)
Optimized for the extended culture of pluripotent stem cell-derived cardiomyocytes. R&D Systems™ StemXVivo Cardiomyocyte Maintenance Media Supplement (50X) is nutrient-rich, fully defined, and serum-free.
R&D Systems™ Cultrex Mouse Collagen IV
Collagen IV is a major component of basement membranes, which underlies epithelial and endothelial cells and surrounds muscle, fat and nerve cells. It can be used as a thin coating on tissue culture surfaces to promote cell attachment and proliferation and to study its effects on cell behavior.
R&D Systems™ ITS Media Supplement (100X)
Supports cell proliferation under low serum conditions. R&D Systems ITS Media Supplement (100X) is a pre-optimized and serum-free media supplement that helps to maintain culture media consistency across passages and experiments.
R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
---|---|
Conjugate | Unconjugated |
Molecular Weight (g/mol) | alpha chain: 53.7 kDa beta chain: 26 kDa |
Gene Symbol | HGF |
Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
Storage Requirements | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
For Use With (Application) | Binding Activity |
Source | Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile) |
Accession Number | P14210.2 |
Regulatory Status | RUO |
Gene Alias | deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A |
Gene ID (Entrez) | 3082 |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Cross Reactivity | HGF |
Species | Human |